# Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

> **NCT06197308** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 28 (estimated)

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

- **DRUG:** oral vancomycin and oral amoxicillin

## Key facts

- **NCT ID:** NCT06197308
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-09-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197308, "Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06197308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*